A SIMPLE KEY FOR AGEN EURO UNVEILED

Emily Bodnar’s ranking relies on the anticipation of important milestones for Agenus in the approaching calendar year, specifically the probable submitting of the Biologics License Application (BLA) for their direct drug applicant, botensilimab (bot). Agenus has dosed in excess of 900 people with bot throughout several solid tumors, showing a com